Department of Biochemistry, Faculty of Natural Sciences, Comenius University in Bratislava, Mlynská Dolina, Ilkovičova 6, 842 15 Bratislava, Slovakia.
Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523-1682, USA.
Int J Mol Sci. 2021 Mar 12;22(6):2884. doi: 10.3390/ijms22062884.
The genome of the human intracellular pathogen encodes an unusually large number of epoxide hydrolases, which are thought to be involved in lipid metabolism and detoxification reactions needed to endure the hostile environment of host macrophages. These enzymes therefore represent suitable targets for compounds such as urea derivatives, which are known inhibitors of soluble epoxide hydrolases. In this work, we studied in vitro the effect of the thiourea drug isoxyl on six epoxide hydrolases of using a fatty acid substrate. We show that one of the proteins inhibited by isoxyl is EphD, an enzyme involved in the metabolism of mycolic acids, key components of the mycobacterial cell wall. By analyzing mycolic acid profiles, we demonstrate the inhibition of EphD epoxide hydrolase activity by isoxyl and two other urea-based inhibitors, thiacetazone and AU1235, inside the mycobacterial cell.
人类细胞内病原体的基因组编码了数量异常多的环氧化物水解酶,这些酶被认为参与脂质代谢和解毒反应,以适应宿主巨噬细胞的恶劣环境。因此,这些酶是尿素衍生物等化合物的合适靶点,尿素衍生物是已知的可溶性环氧化物水解酶抑制剂。在这项工作中,我们使用脂肪酸底物研究了硫脲药物异羟肟酸对 6 种环氧化物水解酶的体外作用。我们表明,异羟肟酸抑制的一种蛋白质是 EphD,它参与分枝杆菌细胞壁关键成分——类脂酸的代谢。通过分析类脂酸图谱,我们证明了异羟肟酸和另外两种基于尿素的抑制剂——硫代乙酰唑胺和 AU1235 在分枝杆菌细胞内抑制 EphD 环氧化物水解酶的活性。